Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer

200982 citationsJournal Articlebronze Open Access

Authors

For patients with stage III colon cancer, the addition of ED to FU-based therapy had no statistically significant effect on OS.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 27, Issue 12, pp. 1941-1947

Field-Weighted Citation Impact: 5.07